Suppr超能文献

台湾北部某大学医院产厄他培南耐药肺炎克雷伯菌菌血症的结局和特征:一项匹配病例对照研究。

Outcomes and characteristics of ertapenem-nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: a matched case-control study.

机构信息

Division of Infectious Diseases, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.

出版信息

J Microbiol Immunol Infect. 2012 Apr;45(2):113-9. doi: 10.1016/j.jmii.2011.09.026. Epub 2011 Dec 11.

Abstract

BACKGROUND AND PURPOSE

Carbapenem-resistant Klebsiella pneumoniae is an emerging problem worldwide. The object of this study was to investigate the risk factors, characteristics and outcomes of ertapenem-nonsusceptible K pneumoniae (ENSKp) bacteremia.

METHODS

We conducted a 1:2 ratio matched case-control study. The controls were randomly selected among patients with ertapenem-susceptible K pneumoniae (ESKp) bacteremia and were matched with ENSKp cases for bacteremia.

RESULTS

Seventy-five patients were included in this study (25 cases and 50 controls). Bivariate analysis showed that prior exposure to either β-Lactam/β-Lactam-lactamase inhibitors (p = 0.008) or 4(th) generation cephalosporins (p < 0.001), chronic obstructive pulmonary disease (COPD) (p = 0.001), acute renal failure (p = 0.021), chronic kidney disease without dialysis (p = 0.021), recent hospital stay (p = 0.016), intensive care unit stay (p = 0.002), mechanical ventilation (p = 0.003), central venous catheter placement (p = 0.016), Foley indwelling (p = 0.022), polymicrobial bacteremia (p = 0.003) and higher Pittsburgh bacteremia score (p < 0.001) were associated with ENSKp bacteremia. The multivariate analysis showed that prior exposure to 4(th) generation cephalosporins (odds ratio [OR], 28.05; 95% confidence interval [CI], 2.92-269.85; p = 0.004), COPD (OR, 21.38; 95% CI, 2.95-154.92; p = 0.002) and higher Pittsburgh bacteremia score (OR, 1.35; 95% CI, 1.10-1.66; p = 0.004) were independent factors for ENSKp bacteremia. ENSKp bacteremia had a higher 14-day mortality rate than ESKp bacteremia (44.0% vs. 22.0%; p = 0.049). The overall in-hospital mortality rates for these two groups were 60.0% and 40.0% respectively (p = 0.102).

CONCLUSION

ENSKp bacteremia had a poor outcome and the risk factors were prior exposure of 4(th) generation cephalosporins, COPD and higher Pittsburgh bacteremia score. Antibiotic stewardship may be the solution for the preventive strategy.

摘要

背景与目的

耐碳青霉烯类肺炎克雷伯菌是全球范围内一个新出现的问题。本研究的目的是探讨厄他培南不敏感肺炎克雷伯菌(ENSKp)菌血症的危险因素、特征和结局。

方法

我们进行了 1:2 比例的病例对照研究。对照组是从厄他培南敏感肺炎克雷伯菌(ESKp)菌血症患者中随机选择的,并与 ENSKp 病例进行了菌血症匹配。

结果

本研究共纳入 75 例患者(25 例病例和 50 例对照)。单因素分析显示,先前暴露于β-内酰胺/β-内酰胺酶抑制剂(p = 0.008)或第 4 代头孢菌素(p < 0.001)、慢性阻塞性肺疾病(COPD)(p = 0.001)、急性肾损伤(p = 0.021)、无透析慢性肾脏病(p = 0.021)、近期住院(p = 0.016)、重症监护病房入住(p = 0.002)、机械通气(p = 0.003)、中心静脉导管置管(p = 0.016)、 Foley 留置(p = 0.022)、混合菌血症(p = 0.003)和较高的匹兹堡菌血症评分(p < 0.001)与 ENSKp 菌血症相关。多因素分析显示,先前暴露于第 4 代头孢菌素(比值比[OR],28.05;95%置信区间[CI],2.92-269.85;p = 0.004)、COPD(OR,21.38;95%CI,2.95-154.92;p = 0.002)和较高的匹兹堡菌血症评分(OR,1.35;95%CI,1.10-1.66;p = 0.004)是 ENSKp 菌血症的独立危险因素。ENSKp 菌血症的 14 天死亡率高于 ESKp 菌血症(44.0% vs. 22.0%;p = 0.049)。两组患者的总住院死亡率分别为 60.0%和 40.0%(p = 0.102)。

结论

ENSKp 菌血症预后不良,危险因素为第 4 代头孢菌素、COPD 和较高的匹兹堡菌血症评分。抗生素管理可能是预防策略的解决方案。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验